PIEZO1 and neoplasm: Chemical or mechanical activation of Piezo1 enhances tumor cell sensitivity to tumor necrosis factor–related apoptosis-inducing ligand (TRAIL)-induced apoptosis, thereby reversing resistance to temozolomide (TMZ) (78, 84), offering a highly specific and minimally invasive therapeutic strategy for this lethal brain tumor.